How Safe Is Johnson & Johnson's Dividend?
Johnson & Johnson (NYSE: JNJ) is one of the best-known companies in America, with most consumers making its over-the-counter products a staple of their medicine cabinets. Yet Johnson & Johnson has gotten a lot more growth from its development of key pharmaceuticals, and the company's impressive pipeline of candidate treatments and medical devices plays an important role in the future of the company.
Dividend investors have gravitated to Johnson & Johnson because of its yield and its long history of raising its quarterly payouts to shareholders for decades. Yet even J&J faces challenges that could hurt the company and its stock. Below, you'll learn more about whether Johnson & Johnson's dividend is safe for investors to count on going forward.
Metric
Source: Fool.com
Johnson & Johnson Stock
The stock is one of the favorites of our community with 39 Buy predictions and 1 Sell predictions.
With a target price of 179 € there is a slightly positive potential of 19.84% for Johnson & Johnson compared to the current price of 149.36 €.
